Table 1.

PSP extract reverses the hepatotoxic effect of DEN/CCl₄ on ALT, AST and ALP levels.

Experimental Groups	Group I	Group II	Group III	Group IV	Group V	Group VI
ALT (U/L) (mean ± SD)	39.57 ± 2.60	243.20 ± 84.73	45.83 ± 2.63	34.90 ± 4.68	36.15 ± 3.80	30.09 ± 3.74
F (p)	35.254* (<0.001)
P1		<0.001*	0.757	0.818	0.866	0.640
P2			<0.001*	<0.001*	<0.001*	<0.001*
P3					0.633
P4						0.812
AST (U/L) (mean ± SD)	158.67 ± 18.75	338.67 ± 103.56	190.17 ± 21.85	139.00 ± 19.96	177.17 ± 29.46	145.50 ± 11.24
F (p)	15.469* (<0.001)
p1		<0.001*	0.249	0.469	0.496	0.627
p2			<0.001*	<0.001*	<0.001*	<0.001*
p3					0.631
p4						0.810
ALP (U/L) (mean ± SD)	168.33 ± 48.14	268.83 ± 26.41	186.17 ± 62.37	198.00 ± 20.79	192.50 ± 19.09	179.83 ± 57.65
F (p)	4.174* (0.005)
p1		<0.001*	0.477	0.240	0.337	0.646
p2			0.002*	0.008*	0.004*	0.001*
p3					0.800
p4						0.469

F: F test (ANOVA), p₁: p value of LSD test between negative control and other groups, p₂: p value of LSD test between group II and group III, IV, V and VI, p₃: p value of LSD test between group III and group V, p₄: p value of LSD test between group IV and group VI, *: Statistically significant at p ≤ 0.05.